# American Academy of Dermatology

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/american-academy-of-dermatology/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 22 |
| Citations | 79,735 |
| City | Schaumburg |
| Country | US |
| Description | American Academy of Dermatology is a research organisation in Schaumburg, US. OpenAlex records 793 works and 79,735 citations for it. 196 researchers list it as their most recent affiliation. |
| Homepage | https://www.aad.org/ |
| OpenAlex ID | https://openalex.org/I2799294867 |
| Region | Illinois |
| Researchers | 196 |
| ROR ID | https://ror.org/00bbqy387 |
| Type | nonprofit |
| Works | 793 |

## University papers

- [Temporal patterns in overweight and obesity in Type 1 diabetes](https://scholariq.org/papers/temporal-patterns-in-overweight-and-obesity-in-type-1-diabetes/)
- [Obesity as a disease: no lightweight matter](https://scholariq.org/papers/obesity-as-a-disease-no-lightweight-matter/)
- [Polycyclic aromatic hydrocarbon biomarkers and serum markers of inflammation. A positive association that is more evident in men](https://scholariq.org/papers/polycyclic-aromatic-hydrocarbon-biomarkers-and-serum-markers-of-inflammation-a/)
- [The obesity epidemic and rising diabetes incidence in a low-income racially diverse southern US cohort](https://scholariq.org/papers/the-obesity-epidemic-and-rising-diabetes-incidence-in-a-low-income-racially/)
- [Glycemic control and fracture risk in elderly patients with diabetes](https://scholariq.org/papers/glycemic-control-and-fracture-risk-in-elderly-patients-with-diabetes/)
- [Perfluoroalkyl substances and beta cell deficient diabetes](https://scholariq.org/papers/perfluoroalkyl-substances-and-beta-cell-deficient-diabetes/)
- [Urinary polycyclic aromatic hydrocarbon biomarkers and diabetes mellitus](https://scholariq.org/papers/urinary-polycyclic-aromatic-hydrocarbon-biomarkers-and-diabetes-mellitus/)
- [Adiposity and mortality in type 1 diabetes](https://scholariq.org/papers/adiposity-and-mortality-in-type-1-diabetes/)
- [Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes](https://scholariq.org/papers/perfluoroalkyl-substances-and-kidney-function-in-chronic-kidney-disease-anemia/)
- [Validating the extract, transform, load process used to populate a large clinical research database](https://scholariq.org/papers/validating-the-extract-transform-load-process-used-to-populate-a-large-clinical/)
- [Perfluoroalkyl substances are inversely associated with coronary heart disease in adults with diabetes](https://scholariq.org/papers/perfluoroalkyl-substances-are-inversely-associated-with-coronary-heart-disease/)
- [Perfluoroalkyl substances and likelihood of stroke in persons with and without diabetes](https://scholariq.org/papers/perfluoroalkyl-substances-and-likelihood-of-stroke-in-persons-with-and-without/)

## University researchers

- [Baqiyyah Conway](https://scholariq.org/researchers/baqiyyah-conway/)

## University top topics

Showing 8 of 24.

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Nail Diseases and Treatments](https://scholariq.org/topics/nail-diseases-and-treatments/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)
- [Skin Protection and Aging](https://scholariq.org/topics/skin-protection-and-aging/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.